These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 26850063)

  • 1. Medical cannabis: considerations for the anesthesiologist and pain physician.
    Beaulieu P; Boulanger A; Desroches J; Clark AJ
    Can J Anaesth; 2016 May; 63(5):608-24. PubMed ID: 26850063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical use of cannabis products: Lessons to be learned from Israel and Canada.
    Ablin J; Ste-Marie PA; Schäfer M; Häuser W; Fitzcharles MA
    Schmerz; 2016 Feb; 30(1):3-13. PubMed ID: 26767992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical Marijuana programs: implications for cannabis control policy--observations from Canada.
    Fischer B; Kuganesan S; Room R
    Int J Drug Policy; 2015 Jan; 26(1):15-9. PubMed ID: 25287942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical cannabis in supportive cancer care: lessons from Canada.
    Arboleda MF; Prosk E; Cyr C; Gamaoun R; Vigano A
    Support Care Cancer; 2020 Jul; 28(7):2999-3001. PubMed ID: 32172409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoids: Medical implications.
    Schrot RJ; Hubbard JR
    Ann Med; 2016; 48(3):128-41. PubMed ID: 26912385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical marijuana: Showdown at the cannabis corral.
    Eisenstein M
    Nature; 2015 Sep; 525(7570):S15-7. PubMed ID: 26398734
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical cannabis access, use, and substitution for prescription opioids and other substances: A survey of authorized medical cannabis patients.
    Lucas P; Walsh Z
    Int J Drug Policy; 2017 Apr; 42():30-35. PubMed ID: 28189912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical use of cannabis and cannabinoids containing products - Regulations in Europe and North America.
    Abuhasira R; Shbiro L; Landschaft Y
    Eur J Intern Med; 2018 Mar; 49():2-6. PubMed ID: 29329891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposed amendments to medical marijuana regulations released for comment.
    Betteridge G
    HIV AIDS Policy Law Rev; 2004 Dec; 9(3):28-9. PubMed ID: 15801111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. U.S. Policy Responses to Calls for the Medical Use of Cannabis.
    Hall W
    Yale J Biol Med; 2015 Sep; 88(3):257-64. PubMed ID: 26339208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dispensaries indispensable? Patient experiences of access to cannabis from medical cannabis dispensaries in Canada.
    Capler R; Walsh Z; Crosby K; Belle-Isle L; Holtzman S; Lucas P; Callaway R
    Int J Drug Policy; 2017 Sep; 47():1-8. PubMed ID: 28667878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use.
    Walsh Z; Callaway R; Belle-Isle L; Capler R; Kay R; Lucas P; Holtzman S
    Int J Drug Policy; 2013 Nov; 24(6):511-6. PubMed ID: 24095000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.
    Ryan J; Sharts-Hopko N
    J Neurosci Nurs; 2017 Jun; 49(3):185-190. PubMed ID: 28471927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CMA position against separate regulations for medical cannabis draws ire and insults.
    Owens B
    CMAJ; 2018 May; 190(18):E574-E575. PubMed ID: 29735538
    [No Abstract]   [Full Text] [Related]  

  • 15. The Changing Drug Culture: Medical and Recreational Marijuana.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():11-7. PubMed ID: 26881768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical marijuana patient counseling points for health care professionals based on trends in the medical uses, efficacy, and adverse effects of cannabis-based pharmaceutical drugs.
    Parmar JR; Forrest BD; Freeman RA
    Res Social Adm Pharm; 2016; 12(4):638-54. PubMed ID: 26443472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequelae of Cannabis as Medicine.
    Finn K
    Pain Med; 2015 Jul; 16(7):1447-9. PubMed ID: 26108137
    [No Abstract]   [Full Text] [Related]  

  • 18. The Dangerous Drugs Act Amendment in Jamaica: Reviewing goals, implementation, and challenges.
    Davenport S; Pardo B
    Int J Drug Policy; 2016 Nov; 37():60-69. PubMed ID: 27596698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and cannabinoids in cancer pain management.
    Meng H; Dai T; Hanlon JG; Downar J; Alibhai SMH; Clarke H
    Curr Opin Support Palliat Care; 2020 Jun; 14(2):87-93. PubMed ID: 32332209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and Cannabinoids for Chronic Pain.
    Romero-Sandoval EA; Kolano AL; Alvarado-Vázquez PA
    Curr Rheumatol Rep; 2017 Oct; 19(11):67. PubMed ID: 28983880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.